Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.320
-0.100 (-7.04%)
At close: Dec 5, 2025, 4:00 PM EST
1.370
+0.050 (3.79%)
After-hours: Dec 5, 2025, 7:57 PM EST

Marker Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-14.3-10.73-8.24-29.93-41.88-28.71
Upgrade
Depreciation & Amortization
----3.161.08
Upgrade
Stock-Based Compensation
0.480.250.863.35.965.23
Upgrade
Other Operating Activities
---5.81-0.28--0.03
Upgrade
Change in Accounts Receivable
-0.92-1.321.37-2.410.06
Upgrade
Change in Accounts Payable
-0.890.01-0.72-1.324.143.05
Upgrade
Change in Unearned Revenue
1.35---1.151.15-
Upgrade
Change in Other Net Operating Assets
-0.540.892.190.1-0.82-0.7
Upgrade
Operating Cash Flow
-14.82-10.91-16.44-26.97-27.28-20.03
Upgrade
Capital Expenditures
-----3.13-9.25
Upgrade
Other Investing Activities
--18.66-4.95--
Upgrade
Investing Cash Flow
--18.66-4.95-3.13-9.25
Upgrade
Issuance of Common Stock
24.7614.991.110.252.566.74
Upgrade
Financing Cash Flow
24.7614.991.110.252.566.74
Upgrade
Net Cash Flow
9.944.083.33-31.7222.14-22.55
Upgrade
Free Cash Flow
-14.82-10.91-16.44-26.97-30.41-29.29
Upgrade
Free Cash Flow Margin
-315.59%-165.53%-496.51%-767.66%-2449.11%-6274.32%
Upgrade
Free Cash Flow Per Share
-1.16-1.22-1.87-3.23-3.98-6.23
Upgrade
Levered Free Cash Flow
-10.88-7.13-10.14-14.77-12.98-18.25
Upgrade
Unlevered Free Cash Flow
-10.88-7.13-10.14-14.77-12.98-18.25
Upgrade
Change in Working Capital
-1-0.422.85-4.765.472.4
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.